Abstract
We conducted a randomized, double-blind trial of 1- versus 4-h infusions of amphotericin B to determine whether there was any difference in infusion-related toxicity. A total of 128 maintenance infusions in 12 patients were studied; 62 were randomized to 1-h infusions (group A) and 66 were randomized to 4-h infusions (group B). We found no significant differences between patients in groups A and B in mean temperature, pulse, or systolic or diastolic blood pressure measured during the infusions. At a significant level of 0.05, the power to detect a mean difference in temperature of 2 degrees C, a pulse difference of 20 beats per min, a decrease in diastolic blood pressure of 10 mm Hg, or a decrease in systolic blood pressure of 20 mm Hg was 0.95. Rigors and chills were noted in 15 of 62 (24.1%) infusions in group A patients and 12 of 66 (18.1%) infusions in group B patients (P = 0.40). Meperidine was required because of severe persistent rigors in 6 of 62 (9.6%) infusions in group A patients and 6 of 66 (8.9%) infusions in group B patients (P = 0.91). An increase in temperature was noted in five (8%) of the group A infusions and seven (10.6%) of the group B infusions (P = 0.63). The mean time to onset of rigors, an increase in temperature, and an increase in pulse occurred significantly earlier in group A than in group B patients (P = 0.02 for all comparisons). We conclude that there is no difference in the incidence or severity of the infusion-related toxicity of amphotericin B with a 1-h infusion rate compared with a 4-h infusion rate. However, the onset of infusion-related toxicity occurs significantly earlier with a 1-h infusion.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arroyo J. C. Amphotericin B fever in rabbits. Life Sci. 1984 Mar 26;34(13):1249–1252. doi: 10.1016/0024-3205(84)90547-2. [DOI] [PubMed] [Google Scholar]
- CASS J. S., CAMPBELL I. R., LANGE L. A guide to production, care and use of laboratory animals. An annotated bibliography. 4. Breeding programs: design and operation of production colony. Fed Proc. 1963 Mar-Apr;Pt 3 22(2):95–102. [PubMed] [Google Scholar]
- Cleary J. D., Weisdorf D., Fletcher C. V. Effect of infusion rate on amphotericin B-associated febrile reactions. Drug Intell Clin Pharm. 1988 Oct;22(10):769–772. doi: 10.1177/106002808802201005. [DOI] [PubMed] [Google Scholar]
- Cockcroft D. W., Gault M. H. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41. doi: 10.1159/000180580. [DOI] [PubMed] [Google Scholar]
- Craven P. C., Gremillion D. H. Risk factors of ventricular fibrillation during rapid amphotericin B infusion. Antimicrob Agents Chemother. 1985 May;27(5):868–871. doi: 10.1128/aac.27.5.868. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DeMonaco H. J., McGovern B. Transient asystole associated with amphotericin B infusion. Drug Intell Clin Pharm. 1983 Jul-Aug;17(7-8):547–548. doi: 10.1177/106002808301700711. [DOI] [PubMed] [Google Scholar]
- Fields B. T., Jr, Bates J. H., Abernathy R. S. Effect of rapid intravenous infusion on serum concentrations of amphotericin B. Appl Microbiol. 1971 Oct;22(4):615–617. doi: 10.1128/am.22.4.615-617.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gross M. H., Pickard W. W., Perfect J. R. Retrospective review of amphotericin B use in a tertiary-care medical center. Am J Hosp Pharm. 1987 Jun;44(6):1353–1357. [PubMed] [Google Scholar]
- Tarala R. A., Smith J. D. CKryptococcosis treated by rapid infusion of amphotericin B. Br Med J. 1980 Jul 5;281(6232):28–28. doi: 10.1136/bmj.281.6232.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Terrell C. L., Hermans P. E. Antifungal agents used for deep-seated mycotic infections. Mayo Clin Proc. 1987 Dec;62(12):1116–1128. doi: 10.1016/s0025-6196(12)62506-3. [DOI] [PubMed] [Google Scholar]